Content Library

Partnership Opportunities

Digital Opportunities Pack: EMAPS 2020

SHARING GLOBAL BUSINESS SOLUTIONS WITH THE WORLD’S LEADERSWith over 47,500 Active Users across our Pharma IQ community, this offers untapped potential to place your brand front of mind and connect with this engaged audience.Grow your business with a captive audience of Pharma and Life Sciences professionals who are looking to unlock...

Industry Content

Trend & Investment Report: Early & Managed Access Programmes

The number of named patient requests has increased overtime due to patients, advocacy groups and physicians becoming increasingly well informed on the developmental pipelines of pharma and biotechs across the world. To keep up with rising demands, pharma companies have had to invest heavily in Early Access Programmes to meet...

European Regulatory Handbook for Early & Managed Access Programmes

With regulations differing between European countries, it’s no easy feat launching an early access programme internationally! Ahead of the Early and Managed Access Programmes Forum taking place this November in London, Pharma IQ has gathered together key regulatory information you need at your fingertips when launching your programme into different...

Five Key Steps for Early Managed Access Programmes

Managing an Expanded Access Programme can bring many challenges for pharma companies, such as navigating the complex regulatory landscape, logistical planning, ethical concerns and unsolicited requests from increasingly well-informed patients. Pharma IQ spoke to Gregory Tuyteleers, Global Operations Lead, Managed Access at Janssen, to gain his expert recommendations on "5...